Markets:

Overview

News

Currencies

International

Treasuries

Landos Biopharma, Inc. - Common Stock (NQ:LABP)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, May 23, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Landos Biopharma, Inc. - Common Stock

< Previous 1 2 3 Next >

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 ↗

January 06, 2023

Via Benzinga

Raymond James Is Bearish On This Inflammatory Bowel Disease Player On Upcoming 'Pipeline Reset' ↗

August 12, 2022

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket ↗

December 30, 2022

Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to...

Via Benzinga

Why IceCure Medical Shares Are Trading Higher By 296%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session ↗

December 20, 2022

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 296% to $3.71 after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 19, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 19, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 16, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 13, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 25, 2022

Via Benzinga

NVIDIA To $225? Plus Raymond James Cuts PT On This Stock By 81% ↗

November 11, 2022

Oppenheimer cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $225. Oppenheimer analyst Rick Schafer maintained an Outperform rating on the stock. NVIDIA shares rose 0.9% to...

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 27, 2022

On Thursday, 111 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 26, 2022

On Wednesday, 53 companies reached new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 20, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 16, 2022

Via Benzinga

Why Super Micro Computer Shares Jumped Over 10%; Here Are 73 Biggest Movers From Yesterday ↗

October 21, 2022

Gainers NextPlay Technologies, Inc. (NASDAQ: NXTP) shares climbed 107.3% to close at $0.4138 on Thursday after the company announced its NextFintech division received commitment for a $15 million...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 11, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022 ↗

August 12, 2022

Via Benzinga

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary ↗

August 03, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 08, 2022

Gainers

Via Benzinga

This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday ↗

June 28, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.

Via Benzinga

Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session ↗

June 27, 2022

Gainers Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 18, 2022

Via Benzinga

7 Hot Upcoming IPOs to Watch For in 2022 ↗

May 16, 2022

There were a record 1,035 IPOs on the U.S. stock market in 2021. Of these, 159 have returned profits to investors. This means that last year, an investor had a 15.36% chance of investing in an IPO that...

Via Benzinga

56 Stocks Moving In Friday's Mid-Day Session ↗

May 13, 2022

Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to...

Via Benzinga

23 Stocks Moving in Friday's Pre-Market Session ↗

May 13, 2022

Gainers OTR Acquisition Corp. (NASDAQ: OTRA) rose 88.7% to $18.21 in pre-market trading after filing on Thursday showed shareholders approved merger with Comera Life Sciences.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

May 13, 2022

Good morning! We're starting off the final day of the workweek with an overview of the biggest pre-market stock movers for Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 12, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 12, 2022

With the start of another day comes our breakdown of the biggest pre-market stock movers and this time it's for Thursday!

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022 ↗

April 12, 2022

Upgrades

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Landos Biopharma, Inc. - Common Stock (NQ:LABP)

Headline News about Landos Biopharma, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today